Joshua B. Cohen, Co-CEO: Amylyx Pharmaceuticals AMLX Sell · Filed 25/01/08

Trade details

Type: Insider sale
Amount: $30,257.55
Shares · price: 7,471 sh · $4.05 a share
Held after: 3,213,098 sh
Stock: Amylyx Pharmaceuticals AMLX
Person: Joshua B. CohenCo-CEO
Trade date: 25/01/06
Filed: 25/01/08
Days to filing: 2 days

Sold 0.2% of holdings

Share of holding sold: 0.2%

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/12/07~25/02/05

Joshua B. Cohen's recent trades

Joshua B. CohenCo-CEO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$980.5K
30,464 sh
$980.5K
Filed 09/11
Traded 09/10
Joshua B. CohenCo-CEO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$424K
29,282 sh
$424K
Filed 03/04
Traded 03/02
Joshua B. CohenCo-CEO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$424.1K
29,282 sh
$424.1K
Filed 03/02
Traded 03/02
Joshua B. CohenCo-CEO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$227.5K
15,500 sh
$227.5K
Filed 02/04
Traded 02/02
Joshua B. CohenCo-CEO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$227.6K
15,500 sh
$227.6K
Filed 02/02
Traded 02/02